Valencia Technologies

Valencia Technologies is a pioneering company in the field of neuromodulation, focusing on the development and commercialization of a revolutionary neurostimulator called eCoin. This tiny, coin-sized device is designed to be implanted subcutaneously in a simple office or outpatient procedure, eliminating the need for lead wires and reducing the risk of wire breaks. The eCoin operates on a low duty cycle, non-constant stimulation principle, challenging traditional neuromodulation methods that rely on constant nerve stimulation. Valencia Technologies serves patients suffering from a variety of chronic conditions, including heart failure, resistant hypertension, osteoarthritis of the knee, depression, erectile dysfunction, pain, and dyslipidemia. The company operates in the medical technology market, combining the large market opportunities and multiple assets typical of biotechnology with the lower risks associated with medtech. Valencia generates revenue through the sale of its eCoin device, which is currently in clinical trials and being manufactured. The business model focuses on providing a cost-effective solution with a low cost of goods sold to price ratio, making it an attractive option for both patients and healthcare providers.

Keywords: neurostimulator, eCoin, subcutaneous, low duty cycle, chronic conditions, clinical trials, medtech, biotechnology, cost-effective, healthcare.